Loading…
Purpuric herpes zoster in patients in therapy with clopidogrel
Highlights • Clopidogrel is a drug used for the prevention of vascular events. • Six clinical varieties of herpes zoster exist. • Haemorrhagic herpes zoster is considered a very rare variety. • We report 3 cases of purpuric herpes zoster in patients during clopidogrel.
Saved in:
| Published in: | Journal of clinical virology 2015-08, Vol.69, p.122-124 |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c441t-ccd223ee4841c706844fc2c90ccb48c8882a24f1de54c314e63bd85bb9a541633 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c441t-ccd223ee4841c706844fc2c90ccb48c8882a24f1de54c314e63bd85bb9a541633 |
| container_end_page | 124 |
| container_issue | |
| container_start_page | 122 |
| container_title | Journal of clinical virology |
| container_volume | 69 |
| creator | Veraldi, S Vaira, F Nazzaro, G |
| description | Highlights • Clopidogrel is a drug used for the prevention of vascular events. • Six clinical varieties of herpes zoster exist. • Haemorrhagic herpes zoster is considered a very rare variety. • We report 3 cases of purpuric herpes zoster in patients during clopidogrel. |
| doi_str_mv | 10.1016/j.jcv.2015.05.028 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1746875710</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1386653215001730</els_id><sourcerecordid>1746875710</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-ccd223ee4841c706844fc2c90ccb48c8882a24f1de54c314e63bd85bb9a541633</originalsourceid><addsrcrecordid>eNqFkUtLxDAUhYMovn-AG-nSTce8mqYIggy-YEBBXYf29o6T2mlr0irjrzdl1IULhQu5kHMOl-8QcsTohFGmTqtJBW8TTlkyoWG43iC7TKciTjKVboZdaBWrRPAdsud9RYNQyHSb7HDFaSYysUvO7wfXDc5CtEDXoY8-Wt-ji2wTdXlvsen9uPfhN-9W0bvtFxHUbWfL9tlhfUC25nnt8fDr3SdPV5eP05t4dnd9O72YxSAl62OAknOBKLVkkFKlpZwDh4wCFFKD1prnXM5ZiYkEwSQqUZQ6KYosTyRTQuyTk3Vu59rXAX1vltYD1nXeYDt4w1KpdJqkjP4vVZnOVDgrC1K2loJrvXc4N52zy9ytDKNmJGwqEwibkbChYbgOnuOv-KFYYvnj-EYaBGdrAQYebxad8RA4ApbWIfSmbO2f8ee_3FDbxkJev-AKfdUOrgmgDTOeG2oexorHhlkS2k0FFZ-0lJ_g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1698964419</pqid></control><display><type>article</type><title>Purpuric herpes zoster in patients in therapy with clopidogrel</title><source>Elsevier</source><creator>Veraldi, S ; Vaira, F ; Nazzaro, G</creator><creatorcontrib>Veraldi, S ; Vaira, F ; Nazzaro, G</creatorcontrib><description>Highlights • Clopidogrel is a drug used for the prevention of vascular events. • Six clinical varieties of herpes zoster exist. • Haemorrhagic herpes zoster is considered a very rare variety. • We report 3 cases of purpuric herpes zoster in patients during clopidogrel.</description><identifier>ISSN: 1386-6532</identifier><identifier>EISSN: 1873-5967</identifier><identifier>DOI: 10.1016/j.jcv.2015.05.028</identifier><identifier>PMID: 26209393</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Acyclovir - analogs & derivatives ; Acyclovir - therapeutic use ; Aged ; Allergy and Immunology ; Antiviral Agents - therapeutic use ; Clopidogrel ; Female ; Haemorrhagic herpes zoster ; Herpes zoster ; Herpes Zoster - drug therapy ; HIV ; Humans ; Infectious Disease ; Male ; Pruritus - drug therapy ; Pruritus - etiology ; Purpuric herpes zoster ; Ticlopidine - analogs & derivatives ; Ticlopidine - therapeutic use ; Treatment Outcome ; Valine - analogs & derivatives ; Valine - therapeutic use</subject><ispartof>Journal of clinical virology, 2015-08, Vol.69, p.122-124</ispartof><rights>Elsevier B.V.</rights><rights>2015 Elsevier B.V.</rights><rights>Copyright © 2015 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-ccd223ee4841c706844fc2c90ccb48c8882a24f1de54c314e63bd85bb9a541633</citedby><cites>FETCH-LOGICAL-c441t-ccd223ee4841c706844fc2c90ccb48c8882a24f1de54c314e63bd85bb9a541633</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26209393$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Veraldi, S</creatorcontrib><creatorcontrib>Vaira, F</creatorcontrib><creatorcontrib>Nazzaro, G</creatorcontrib><title>Purpuric herpes zoster in patients in therapy with clopidogrel</title><title>Journal of clinical virology</title><addtitle>J Clin Virol</addtitle><description>Highlights • Clopidogrel is a drug used for the prevention of vascular events. • Six clinical varieties of herpes zoster exist. • Haemorrhagic herpes zoster is considered a very rare variety. • We report 3 cases of purpuric herpes zoster in patients during clopidogrel.</description><subject>Acyclovir - analogs & derivatives</subject><subject>Acyclovir - therapeutic use</subject><subject>Aged</subject><subject>Allergy and Immunology</subject><subject>Antiviral Agents - therapeutic use</subject><subject>Clopidogrel</subject><subject>Female</subject><subject>Haemorrhagic herpes zoster</subject><subject>Herpes zoster</subject><subject>Herpes Zoster - drug therapy</subject><subject>HIV</subject><subject>Humans</subject><subject>Infectious Disease</subject><subject>Male</subject><subject>Pruritus - drug therapy</subject><subject>Pruritus - etiology</subject><subject>Purpuric herpes zoster</subject><subject>Ticlopidine - analogs & derivatives</subject><subject>Ticlopidine - therapeutic use</subject><subject>Treatment Outcome</subject><subject>Valine - analogs & derivatives</subject><subject>Valine - therapeutic use</subject><issn>1386-6532</issn><issn>1873-5967</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqFkUtLxDAUhYMovn-AG-nSTce8mqYIggy-YEBBXYf29o6T2mlr0irjrzdl1IULhQu5kHMOl-8QcsTohFGmTqtJBW8TTlkyoWG43iC7TKciTjKVboZdaBWrRPAdsud9RYNQyHSb7HDFaSYysUvO7wfXDc5CtEDXoY8-Wt-ji2wTdXlvsen9uPfhN-9W0bvtFxHUbWfL9tlhfUC25nnt8fDr3SdPV5eP05t4dnd9O72YxSAl62OAknOBKLVkkFKlpZwDh4wCFFKD1prnXM5ZiYkEwSQqUZQ6KYosTyRTQuyTk3Vu59rXAX1vltYD1nXeYDt4w1KpdJqkjP4vVZnOVDgrC1K2loJrvXc4N52zy9ytDKNmJGwqEwibkbChYbgOnuOv-KFYYvnj-EYaBGdrAQYebxad8RA4ApbWIfSmbO2f8ee_3FDbxkJev-AKfdUOrgmgDTOeG2oexorHhlkS2k0FFZ-0lJ_g</recordid><startdate>20150801</startdate><enddate>20150801</enddate><creator>Veraldi, S</creator><creator>Vaira, F</creator><creator>Nazzaro, G</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>20150801</creationdate><title>Purpuric herpes zoster in patients in therapy with clopidogrel</title><author>Veraldi, S ; Vaira, F ; Nazzaro, G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-ccd223ee4841c706844fc2c90ccb48c8882a24f1de54c314e63bd85bb9a541633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Acyclovir - analogs & derivatives</topic><topic>Acyclovir - therapeutic use</topic><topic>Aged</topic><topic>Allergy and Immunology</topic><topic>Antiviral Agents - therapeutic use</topic><topic>Clopidogrel</topic><topic>Female</topic><topic>Haemorrhagic herpes zoster</topic><topic>Herpes zoster</topic><topic>Herpes Zoster - drug therapy</topic><topic>HIV</topic><topic>Humans</topic><topic>Infectious Disease</topic><topic>Male</topic><topic>Pruritus - drug therapy</topic><topic>Pruritus - etiology</topic><topic>Purpuric herpes zoster</topic><topic>Ticlopidine - analogs & derivatives</topic><topic>Ticlopidine - therapeutic use</topic><topic>Treatment Outcome</topic><topic>Valine - analogs & derivatives</topic><topic>Valine - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Veraldi, S</creatorcontrib><creatorcontrib>Vaira, F</creatorcontrib><creatorcontrib>Nazzaro, G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Journal of clinical virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Veraldi, S</au><au>Vaira, F</au><au>Nazzaro, G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Purpuric herpes zoster in patients in therapy with clopidogrel</atitle><jtitle>Journal of clinical virology</jtitle><addtitle>J Clin Virol</addtitle><date>2015-08-01</date><risdate>2015</risdate><volume>69</volume><spage>122</spage><epage>124</epage><pages>122-124</pages><issn>1386-6532</issn><eissn>1873-5967</eissn><abstract>Highlights • Clopidogrel is a drug used for the prevention of vascular events. • Six clinical varieties of herpes zoster exist. • Haemorrhagic herpes zoster is considered a very rare variety. • We report 3 cases of purpuric herpes zoster in patients during clopidogrel.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>26209393</pmid><doi>10.1016/j.jcv.2015.05.028</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1386-6532 |
| ispartof | Journal of clinical virology, 2015-08, Vol.69, p.122-124 |
| issn | 1386-6532 1873-5967 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1746875710 |
| source | Elsevier |
| subjects | Acyclovir - analogs & derivatives Acyclovir - therapeutic use Aged Allergy and Immunology Antiviral Agents - therapeutic use Clopidogrel Female Haemorrhagic herpes zoster Herpes zoster Herpes Zoster - drug therapy HIV Humans Infectious Disease Male Pruritus - drug therapy Pruritus - etiology Purpuric herpes zoster Ticlopidine - analogs & derivatives Ticlopidine - therapeutic use Treatment Outcome Valine - analogs & derivatives Valine - therapeutic use |
| title | Purpuric herpes zoster in patients in therapy with clopidogrel |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T05%3A25%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Purpuric%20herpes%20zoster%20in%20patients%20in%20therapy%20with%20clopidogrel&rft.jtitle=Journal%20of%20clinical%20virology&rft.au=Veraldi,%20S&rft.date=2015-08-01&rft.volume=69&rft.spage=122&rft.epage=124&rft.pages=122-124&rft.issn=1386-6532&rft.eissn=1873-5967&rft_id=info:doi/10.1016/j.jcv.2015.05.028&rft_dat=%3Cproquest_cross%3E1746875710%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c441t-ccd223ee4841c706844fc2c90ccb48c8882a24f1de54c314e63bd85bb9a541633%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1698964419&rft_id=info:pmid/26209393&rfr_iscdi=true |